Group therapy for stroke survivors
Acceptance and Commitment Therapy-based Group Therapy for Mental Health After Stroke - a Pilot Study
This study is testing a group therapy program to see if it helps stroke survivors who are dealing with stress feel better and if it's a good fit for them.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 12 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Bielefeld University Academic / other |
| Locations | 1 site (Bielefeld) |
| Trial ID | NCT06282029 on ClinicalTrials.gov |
What this trial studies
This pilot trial aims to evaluate the feasibility, acceptance, and preliminary efficacy of a group psychotherapy program based on Acceptance and Commitment Therapy for stroke survivors experiencing psychological stress. Participants will engage in 8 weekly sessions lasting 90 minutes each, utilizing a manual adapted for the specific needs of this population. The study will assess whether the therapy is practical and well-received by both participants and therapists, as well as gather initial data on its effectiveness in improving mental health outcomes.
Who should consider this trial
Good fit: Ideal candidates are stroke survivors who exhibit elevated levels of depression, anxiety, or stress as indicated by the DASS-21 scale and have sufficient cognitive and language abilities.
Not a fit: Patients with severe mental disorders, behavioral issues, or those currently undergoing other forms of psychotherapy may not benefit from this study.
Why it matters
Potential benefit: If successful, this therapy could significantly enhance the mental health and quality of life for stroke survivors dealing with depression, anxiety, and stress.
How similar studies have performed: While this approach is adapted for stroke survivors, similar group therapy interventions have shown promise in other populations, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Value above a cut-off on one of the DASS-21 subscales (depression \> 10, anxiety \> 6, and stress \> 10) * Sufficient cognition and language ability (clinical rating) * Sufficient therapy motivation (clinical rating) Exclusion Criteria: * Behavioral disorders (e.g., high irritability or apathy in clinical rating) * Other severe mental disorder (dementia, psychosis, personality disorders, intellectual disability) * Parallel psychotherapy or neuropsychological therapy
Where this trial is running
Bielefeld
- University Neuropsychological Outpatient Clinic — Bielefeld, Germany (Recruiting)
Study contacts
- Principal investigator: Simon Ladwig, PhD — Bielefeld University
- Study coordinator: Simon Ladwig, PhD
- Email: simon.ladwig@uni-bielefeld.de
- Phone: +49521 106 67533
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.